BusinessAmerican Health Council Honors Paul M. Colombani, MD, FACS, FAAP as “Best in Medicine”By Nasdaq OMXNov 22, 2017, 1:00 PM UTC
BusinessTESARO Secures $500 Million Non-Dilutive Term Loan FinancingBy Nasdaq OMXNov 21, 2017, 1:01 PM UTC
BusinessCrownBio Launches an Innovative Grant Program to Fund Advancements in Preclinical Oncology ResearchBy Nasdaq OMXNov 17, 2017, 4:53 PM UTC
BusinessRafael Pharmaceuticals, in Collaboration with Atlantic Health System, Announces Initiation of a Phase I Study of CPI-613 in Combination with Gemcitabine and Nab-Paclitaxel for Patients with Locally Advanced or Metastatic Pancreatic CancerBy Nasdaq OMXNov 16, 2017, 2:24 PM UTC
BusinessA call for action to patient entrepreneurs in the area of cancer to compete at the Lyfebulb-Helsinn Summit for the first ever Lyfebulb-Helsinn Innovation AwardBy Nasdaq OMXNov 15, 2017, 12:01 PM UTC
BusinessActinium Pharmaceuticals Launches the AWE Program aka Actinium Warhead Enabling Program to Enable Collaborations Based on Its Actinium-225 Technology PlatformBy Nasdaq OMXNov 14, 2017, 1:01 PM UTC
BusinessCORRECTING and REPLACING -- Celsion Files Immunotherapy Clinical Protocol for the Evaluation of GEN-1 to Treat Newly Diagnosed Ovarian CancerBy Nasdaq OMXNov 14, 2017, 12:23 AM UTC
